| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $25.1M | -78.3% |
| R&D Expense | $83.9M | -27.2% |
| SG&A Expense | $41.5M | +4.6% |
| Operating Income | -$100.4M | -154.7% |
| Interest Expense | $1.1M | +741.7% |
| Net Income | -$111.6M | -264.8% |
| EPS (Basic) | -$1.27 | -144.2% |
| EPS (Diluted) | -$1.27 | -144.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $189.6M | +32.0% |
| Accounts Receivable | $720K | +47.5% |
| Current Assets | $199.1M | +23.1% |
| Total Assets | $238.2M | +12.6% |
| Current Liabilities | $59.7M | +65.8% |
| Long-term Debt | $22.2M | +796.8% |
| Total Liabilities | $177.7M | +47.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$45.8M | -321.6% |
| Investing Cash Flow | -$3.3M | +42.8% |
| Financing Cash Flow | $95.0M | +34.7% |
| Stockholders' Equity |
| $60.4M |
| -33.7% |